## UHS: Universal Health Services, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.6% below STRENGTH zone (4.0-10.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($213.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Coppell Advisory Solutions LLC Takes $1.28 Million Position in Universal Health Services, Inc. $UHS**
- Source: MarketBeat | 20251215T150910 | Somewhat-Bullish | Relevance: 100%
- Coppell Advisory Solutions LLC initiated a new position in Universal Health Services, Inc. (UHS), acquiring 7,204 shares valued at $1.28 million in Q2, contributing to significant institutional ownership. Universal Health Services reported strong Q2 earnings, with EPS of $5.69 and revenue of $4.50 billion, exceeding analyst estimates, and has a consensus "Hold" rating from analysts. The company also declared a quarterly dividend of $0.20, while corporate insiders recently sold shares.

**2. Ensign Group expands foothold in three US states with facility buyouts**
- Source: MSN | 20251216T110909 | Somewhat-Bullish | Relevance: 64%
- The Ensign Group recently expanded its presence by acquiring facilities in Texas, Arizona, and California. This strategic move aims to strengthen its portfolio of skilled nursing and assisted living operations across these key states. The company continues to focus on growing its healthcare services.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Guggenheim | $274 | $253 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Guggenheim | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($11.07M) |
| Sells | 3 ($30.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-3.4%)
- First Eagle Investme: 8.4% (+0.0%)
- Blackrock Inc.: 8.0% (-11.9%)
- State Street Corpora: 4.7% (-3.1%)
- FMR, LLC: 3.8% (+0.1%)

### Key Risks

1. Heavy insider selling: $31M sold (3 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Analyst sentiment positive (1 raises, avg +8%). Insider selling cluster ($30.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.3B |
| Beta | 1.27 |
| 52W Range | $152.33 - $246.33 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 9.5 |
| Current P/E | 10.3 |
| YoY Growth | 8.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -5.0% to -0.6% (+4.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.6pp (needs >4.0% for momentum thesis). MRS_5 turning positive (2.5%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.18x) but short-term weakness (below SMA20). MACD histogram bearish (-1.87), momentum weakening. RSI neutral at 48. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.60% (CS: 26) | Neutral |
| RSI_14 | 47.7 | Neutral |
| MACD Histogram | -1.87 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.178x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $224.90
- **Stop Loss:** $213.40 (5.1% risk)
- **Target:** $236.40 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $20,915.70
- **Portfolio %:** 20.92%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-25 (Est: $5.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.95 | $5.69 | +14.9% |
| 2025Q2 | $4.96 | $5.35 | +8.0% |
| 2025Q1 | $4.36 | $4.84 | +11.1% |
| 2024Q4 | $4.18 | $4.92 | +17.8% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*